These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22318669)

  • 1. Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH).
    Joglekar MV; Quintana Diez PM; Marcus S; Qi R; Espinasse B; Wiesner MR; Pempe E; Liu J; Monroe DM; Arepally GM
    Thromb Haemost; 2012 Apr; 107(4):717-25. PubMed ID: 22318669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
    Krauel K; Hackbarth C; Fürll B; Greinacher A
    Blood; 2012 Feb; 119(5):1248-55. PubMed ID: 22049520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia.
    Rauova L; Poncz M; McKenzie SE; Reilly MP; Arepally G; Weisel JW; Nagaswami C; Cines DB; Sachais BS
    Blood; 2005 Jan; 105(1):131-8. PubMed ID: 15304392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partially desulfated heparin modulates the interaction between anti-protamine/heparin antibodies and platelets.
    Jouni R; Zöllner H; Khadour A; Wesche J; Grotevendt A; Brandt S; Delcea M; Krauel K; Schwertz H; Sachs UJ; Greinacher A; Bakchoul T
    Thromb Haemost; 2016 Jan; 115(2):324-32. PubMed ID: 26423467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia.
    Tkaczynski E; Arulselvan A; Tkaczynski J; Avery S; Xiao L; Torok-Storb B; Abrams K; Rao NV; Johnson G; Kennedy TP; Poncz M; Lambert MP
    Blood Adv; 2018 Apr; 2(7):754-761. PubMed ID: 29599195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
    Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
    Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
    J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
    Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of complexes of PF4 and heparins by size-exclusion chromatography coupled with multi-angle light scattering detector.
    Zhao J; Xue Y; Tian H; Qiu P; Ouyang Y; Liu H; Yi L; Zhang Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():124004. PubMed ID: 38199058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin modifies the immunogenicity of positively charged proteins.
    Chudasama SL; Espinasse B; Hwang F; Qi R; Joglekar M; Afonina G; Wiesner MR; Welsby IJ; Ortel TL; Arepally GM
    Blood; 2010 Dec; 116(26):6046-53. PubMed ID: 20852126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epitope specificity of heparin-induced thrombocytopenia.
    Horsewood P; Warkentin TE; Hayward CP; Kelton JG
    Br J Haematol; 1996 Oct; 95(1):161-7. PubMed ID: 8857955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low anticoagulant heparin blocks thrombin-induced endothelial permeability in a PAR-dependent manner.
    Gonzales JN; Kim KM; Zemskova MA; Rafikov R; Heeke B; Varn MN; Black S; Kennedy TP; Verin AD; Zemskov EA
    Vascul Pharmacol; 2014 Aug; 62(2):63-71. PubMed ID: 24469066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.
    Rauova L; Zhai L; Kowalska MA; Arepally GM; Cines DB; Poncz M
    Blood; 2006 Mar; 107(6):2346-53. PubMed ID: 16304054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT.
    Kowalska MA; Krishnaswamy S; Rauova L; Zhai L; Hayes V; Amirikian K; Esko JD; Bougie DW; Aster RH; Cines DB; Poncz M
    Blood; 2011 Sep; 118(10):2882-8. PubMed ID: 21772054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical Characteristics of Platelet Factor 4 under Various Conditions are Relevant for Heparin-Induced Thrombocytopenia Testing.
    Bui VC; Gebicka P; Hippe H; Raschke R; Nguyen TL; Greinacher A; Nguyen TH
    J Phys Chem B; 2020 Feb; 124(8):1438-1443. PubMed ID: 31944769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.
    Warkentin TE; Cook RJ; Marder VJ; Sheppard JA; Moore JC; Eriksson BI; Greinacher A; Kelton JG
    Blood; 2005 Dec; 106(12):3791-6. PubMed ID: 16109780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity.
    Brandt S; Krauel K; Gottschalk KE; Renné T; Helm CA; Greinacher A; Block S
    Thromb Haemost; 2014 Jul; 112(1):53-64. PubMed ID: 24671506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.
    Horne MK; Hutchison KJ
    Am J Hematol; 1998 May; 58(1):24-30. PubMed ID: 9590145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
    Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
    Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.